Total Liabilities - Arcellx Inc (NASDAQ:ACLX) - Alpha Spread
A

Arcellx Inc
NASDAQ:ACLX

Watchlist Manager
Arcellx Inc
NASDAQ:ACLX
Watchlist
Price: 86.61 USD 1.38% Market Closed
Market Cap: 4.6B USD
Have any thoughts about
Arcellx Inc?
Write Note

Arcellx Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arcellx Inc
Total Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
A
Arcellx Inc
NASDAQ:ACLX
Total Liabilities
$339.8m
CAGR 3-Years
261%
CAGR 5-Years
182%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Liabilities
$135.2B
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
19%
Gilead Sciences Inc
NASDAQ:GILD
Total Liabilities
$35.3B
CAGR 3-Years
-10%
CAGR 5-Years
-3%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Total Liabilities
$85B
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Liabilities
$5.4B
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
19%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Liabilities
$7.9B
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
22%

See Also

What is Arcellx Inc's Total Liabilities?
Total Liabilities
339.8m USD

Based on the financial report for Dec 31, 2023, Arcellx Inc's Total Liabilities amounts to 339.8m USD.

What is Arcellx Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
182%

Over the last year, the Total Liabilities growth was 212%. The average annual Total Liabilities growth rates for Arcellx Inc have been 261% over the past three years , 182% over the past five years .

Back to Top